Here are seven thoughts:
1. John Nosenzo will serve as the new chief commercial officer, effective Feb. 6, 2017.
2. In his new role, Mr. Nosenzo will head Bioventus’ global sales and distributor management functions.
3. Mr. Nosenzo will also oversee global marketing for the Active Healing Therapies business as well as key customer interface functions responsible for expanding product market access and providing reimbursement services for the EXOGEN Ultrasound Bone Healing System.
4. He will report to CEO Tony Bihl.
5. Equipped with more than 25 years of progressive sales and marketing leadership, Mr. Nosenzo has spent his career in the pharmaceuticals and medical diagnostic markets.
6. He previously served as Beckman Coulter Diagnostics’ senior vice president of global customer operations.
7. Mr. Nosenzo holds a MBA in marketing and management form Adelphi University in Garden City, N.Y.
More articles on devices:
Why 2017 is a big year for minimally invasive spine surgery: Q&A with Paradigm Spine Chairman & CEO Marc Viscogliosi
Global orthopedic devices market to grow at 5% CAGR through 2022 — 3 observations
Zimmer Biomet, Implanet, Spinal Elements & more: 8 device company key notes
